Although KRASG12V is one of the most well-studied oncogenic forms of KRAS (Muñoz-Maldonado et al., 2019), several other KRASG12X mutations are found in human cancers (Hobbs et al., 2016; Timar and Kashofer, 2020). This evidence concerns the gene KRAS and cancer.